| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |